Richline Pharma Ltd
About Richline Pharma Ltd
Data last updated:
Richline Pharma Ltd is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1992PLC014809.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.18 Cr. It is led by directors including Subba Rao Yarapotina and Vijay Kumar Desa.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 8 – 3 – 977/9/3 Srinivasa Apts. Srinagar Colony, Hyderabad, Telangana, India – 500073.
As per MCA filings, the company has open charges of ₹1.75 Cr on record. Court records list 27 cases involving the company, including 16 filed by the company and 11 filed against it; 2 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Richline Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG1992PLC014809, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1992PLC014809 | Current |
| L24239TG1992PLC014809 | Previous |
| L24239AP1992PLC014809 | Previous |
Contact details
Richline Pharma Ltd's registered office is in Hyderabad, Telangana.
- Registered Address8 – 3 – 977/9/3 Srinivasa Apts. Srinagar Colony, Hyderabad, Telangana, India – 500073
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Richline Pharma Ltd
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Richline Pharma Ltd, buy the company report.
Board of directors of Richline Pharma Ltd
Richline Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subba Rao Yarapotina | Director | 30 Sep 1992 | 34 Years 0 Months | Current |
| Vijay Kumar Desa | Director | 17 Jan 2007 | 19 Years 9 Months | Current |
| Yerapotina Sri Ramesh Babu | Director | 30 Sep 1992 | 34 Years 0 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jan 1996 | 90135544 | Canara Bank | ₹25 Lakh | Open | |
| 24 Oct 1995 | 90135519 | Canara Bank | ₹15 Lakh | Open | |
| 05 Oct 1995 | 90135515 | Canara Bank | ₹25 Lakh | Open | |
| 24 Aug 1994 | 90135390 | Canara Bank | ₹1.1 Cr | Open |
Total charge records: 4 View all charges
Legal cases
Richline Pharma Ltd has 27 court cases on record: 16 filed by Richline Pharma, 11 filed against it. 2 cases are pending and 25 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 20 | 8 | 2 |
| Supreme Court | 4 | 0 | 0 |
| District courts | 3 | 3 | 0 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Appeal | Filed against the company by M/S. North East Securities Ltd., | Disposed |
| Supreme Court | Court case (1418-Criminal Matters : Others) | Filed by the company against M/S.Vadilal Chemicals Ltd. | Disposed |
| Supreme Court | Court case (1418-Criminal Matters : Others) | Filed by the company against M/S North East Securities Ltd. . | Disposed |
| High Court, TELANGANA | Revision petition | Filed against the company by M/S North East Securities Ltd. | Disposed |
| High Court, TELANGANA | Court case (CRLP) | Filed by the company against M/S.North-East Securities Ltd.& State | Disposed |
To see the full case history of Richline Pharma Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Richline Pharma Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Richline Pharma Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Richline Pharma Ltd has 3 board changes on record since 1992: 3 appointments. The latest: Vijay Kumar Desa was appointed as Director on 17 Jan 2007.
Frequently asked questions
Richline Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 1992 (34+ years old) and is registered under CIN U24239TG1992PLC014809.
Richline Pharma has 3 current directors:
- Subba Rao Yarapotina - Director
- Vijay Kumar Desa - Director
- Yerapotina Sri Ramesh Babu - Director
The latest financial statements of Richline Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Richline Pharma is U24239TG1992PLC014809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Richline Pharma has 27 court cases on record: 16 filed by the company and 11 filed against it. 2 are pending. Most are in the high courts.
Richline Pharma was incorporated on 30 September 1992, making it 34+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vijay Kumar Desa was appointed as Director on 17 Jan 2007. Subba Rao Yarapotina was appointed as Director on 30 Sep 1992. Yerapotina Sri Ramesh Babu was appointed as Director on 30 Sep 1992.
The registered office of Richline Pharma is at 8 – 3 – 97793 Srinivasa Apts. Srinagar Colony, Hyderabad, Telangana, India – 500073.
Richline Pharma operates in the pharma industry, in the drug formulation and development segment.
Richline Pharma has open charges of ₹1.75 Cr and no satisfied charges on record as per latest MCA filings.